Interviews with Indigenous M āori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial

ConclusionM āori experienced open-source AID positively, and aspired to use this therapy; however, structural and socio-economic barriers to equity were identified. This research proposes strength-based solutions which should be considered in the redesign of diabetes services to improve health outcomes for Mā ori with T1D.Trial Registration: The CREATE trial, encompassing this qualitative sub-study, was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12620000034932p) on the 20th January 2020.
Source: Journal of Diabetes and Metabolic Disorders - Category: Endocrinology Source Type: research